Medical Device News Magazine

Eisai Signs Research Collaboration Agreement with The National Center of Neurology and Psychiatry to Initiate Apolipoprotein E Genetic Testing in the “AD-DMT Registry” in Japan

Eisai and Biogen Japan will continue to contribute to the [...]

By |2024-11-26T09:12:12+00:00November 26, 2024|3rd Party Medical Device Industry News|Comments Off on Eisai Signs Research Collaboration Agreement with The National Center of Neurology and Psychiatry to Initiate Apolipoprotein E Genetic Testing in the “AD-DMT Registry” in Japan

Minimally Invasive Procedure Making Treatment Possible for More People with Normal Pressure Hydrocephalus | By Dan Levangie, President and CEO of CereVasc

Dan Levangie writes: CereVasc’s eShunt System is sparking interest across [...]

By |2024-11-22T12:34:38+00:00November 22, 2024|3rd Party Medical Device Industry News|Comments Off on Minimally Invasive Procedure Making Treatment Possible for More People with Normal Pressure Hydrocephalus | By Dan Levangie, President and CEO of CereVasc

The Role of Endovascular Specialists in the Multidisciplinary Approach to Postpartum Hemorrhage | By Dr. Adam Power, Co-Founder and CMO, Front Line Medical Technologies

Postpartum hemorrhage (PPH) continues to challenge obstetric care despite ongoing [...]

By |2024-11-21T11:42:52+00:00November 21, 2024|3rd Party Medical Device Industry News|Comments Off on The Role of Endovascular Specialists in the Multidisciplinary Approach to Postpartum Hemorrhage | By Dr. Adam Power, Co-Founder and CMO, Front Line Medical Technologies
Go to Top